These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36304147)

  • 1. The status of industrialization and development of exosomes as a drug delivery system: A review.
    Yin Y; Han X; Li C; Sun T; Li K; Liu X; Liu M
    Front Pharmacol; 2022; 13():961127. PubMed ID: 36304147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes: Large-scale production, isolation, drug loading efficiency, and biodistribution and uptake.
    Kimiz-Gebologlu I; Oncel SS
    J Control Release; 2022 Jul; 347():533-543. PubMed ID: 35597405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design strategies and application progress of therapeutic exosomes.
    Liu C; Su C
    Theranostics; 2019; 9(4):1015-1028. PubMed ID: 30867813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mononuclear phagocyte system blockade improves therapeutic exosome delivery to the myocardium.
    Wan Z; Zhao L; Lu F; Gao X; Dong Y; Zhao Y; Wei M; Yang G; Xing C; Liu L
    Theranostics; 2020; 10(1):218-230. PubMed ID: 31903116
    [No Abstract]   [Full Text] [Related]  

  • 5. Exosome-Based Delivery of Natural Products in Cancer Therapy.
    Song H; Liu B; Dong B; Xu J; Zhou H; Na S; Liu Y; Pan Y; Chen F; Li L; Wang J
    Front Cell Dev Biol; 2021; 9():650426. PubMed ID: 33738290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug loading techniques for exosome-based drug delivery systems.
    Xi XM; Xia SJ; Lu R
    Pharmazie; 2021 Feb; 76(2):61-67. PubMed ID: 33714281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome-mimetic nanoplatforms for targeted cancer drug delivery.
    Vázquez-Ríos AJ; Molina-Crespo Á; Bouzo BL; López-López R; Moreno-Bueno G; de la Fuente M
    J Nanobiotechnology; 2019 Jul; 17(1):85. PubMed ID: 31319859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State-of-the-art exosome loading and functionalization techniques for enhanced therapeutics: a review.
    Donoso-Quezada J; Ayala-Mar S; González-Valdez J
    Crit Rev Biotechnol; 2020 Sep; 40(6):804-820. PubMed ID: 32605394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
    Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy.
    Wang X; Zhang H; Yang H; Bai M; Ning T; Li S; Li J; Deng T; Ying G; Ba Y
    Curr Cancer Drug Targets; 2018; 18(4):347-354. PubMed ID: 28699500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosome: a significant nano-scale drug delivery carrier.
    Peng H; Ji W; Zhao R; Yang J; Lu Z; Li Y; Zhang X
    J Mater Chem B; 2020 Sep; 8(34):7591-7608. PubMed ID: 32697267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosome-Based Carrier for RNA Delivery: Progress and Challenges.
    Lu Y; Huang W; Li M; Zheng A
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes as Drug Delivery Systems: Endogenous Nanovehicles for Treatment of Systemic Lupus Erythematosus.
    Ortega A; Martinez-Arroyo O; Forner MJ; Cortes R
    Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33374908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research Progress in Exosome-Based Nanoscale Drug Carriers in Tumor Therapies.
    Fu W; Li T; Chen H; Zhu S; Zhou C
    Front Oncol; 2022; 12():919279. PubMed ID: 35800056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement, scaling-up, and downstream analysis of exosome production.
    Jafari D; Malih S; Eini M; Jafari R; Gholipourmalekabadi M; Sadeghizadeh M; Samadikuchaksaraei A
    Crit Rev Biotechnol; 2020 Dec; 40(8):1098-1112. PubMed ID: 32772758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
    Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
    J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy.
    Johnsen KB; Gudbergsson JM; Skov MN; Pilgaard L; Moos T; Duroux M
    Biochim Biophys Acta; 2014 Aug; 1846(1):75-87. PubMed ID: 24747178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Delivery of Exosomes Armed with Anti-Cancer Therapeutics.
    Choi H; Yim H; Park C; Ahn SH; Ahn Y; Lee A; Yang H; Choi C
    Membranes (Basel); 2022 Jan; 12(1):. PubMed ID: 35054611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases.
    Xitong D; Xiaorong Z
    Gene; 2016 Jan; 575(2 Pt 2):377-384. PubMed ID: 26341056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient exosome delivery in refractory tissues assisted by ultrasound-targeted microbubble destruction.
    Sun W; Li Z; Zhou X; Yang G; Yuan L
    Drug Deliv; 2019 Dec; 26(1):45-50. PubMed ID: 30744440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.